Key result
Antitachycardia pacing terminated fast ventricular arrhythmias (≥188 bpm) in 3 of 4 episodes, and prolonging detection intervals significantly reduced unnecessary ICD shocks.
Why the study?
Does optimized ICD programming with prolonged detection intervals and antitachycardia pacing reduce unnecessary shocks in patients with ICDs?
Does optimized ICD programming with prolonged detection intervals and antitachycardia pacing reduce unnecessary shocks in patients with ICDs?
Optimizing ICD programming with prolonged detection intervals and antitachycardia pacing effectively reduces inappropriate shocks and associated morbidity.
Answers are grounded in this paper and cite their sources.
May reduce unnecessary ICD shocks; leaves open confirmation in prospective randomized trials.
With the increasing numbers of patients with implantable cardioverter/defibrillators for primary prevention (PP), the topic of inappropriate therapy becomes more and more important. If a shock intervention, e.g. for rapidly conducted atrial fibrillation or fast VT (FVT), represents the first reminder of the implantable cardioverter/defibrillator (ICD), the adherence to the therapy will decrease. Moreover, anxiety to receive the next inappropriate ICD Rx is able to initiate a bad quality of life or depression. Starting with the PainFREE Rx II Trial results, the programming of antitachycardia pacing was able to terminate even fast ventricular arrhythmia, i.e. ≥ 188 bpm, in three of four episodes. Thereafter, several studies evaluated whether a prolongation in ventricular tachyarrhythmia (VT) detection is able to reduce unnecessary ICD Rx owing to nonsustained VT. The PREPARE trial evaluated this concept in a cohort of PP patients. This nonrandomized study compared a historical control group to patients with a prolonged detection interval. The results underline the idea that an extension in detection time leads to a significant decrease in ICD Rx for supra- as well as VT. The RELEVANT study investigated in a randomized fashion the outcome of an increase in detection time in nonischemic patients under CRT including an ICD. The findings clearly demonstrated a reduction in ICD Rx as well as hospital admissions, significantly. Currently, the ADVANCE III trial investigates a 30/40 interval detection compared to 18/24 for FVT in prospective randomized fashion in patients for primary or secondary prevention including all ICD devices.
No takes yet. Share an insight, caveat, or question.
Joerg O. Schwab (2010) conducted a review in Implantable cardioverter/defibrillators for primary prevention. Optimized ICD programming (prolonged detection intervals and antitachycardia pacing) vs. Standard programming was evaluated on ICD shocks and inappropriate therapy. Antitachycardia pacing terminated fast ventricular arrhythmias (≥188 bpm) in 3 of 4 episodes, and prolonging detection intervals significantly reduced unnecessary ICD shocks.
Synapse has enriched 10 related papers. Consider them for comparative context: